MIST: Milestone Pharmaceuticals Inc. Stock

by  •  • Comments Off on MIST: Milestone Pharmaceuticals Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 86.61
Enterprise Value ($M) 95.81
Book Value ($M) -6.12
Book Value / Share -0.11
Price / Book -14.15
NCAV ($M) -7.53
NCAV / Share -0.14
Price / NCAV -11.50

Profitability (mra)
Return on Invested Capital (ROIC) -1.05
Return on Assets (ROA) -0.54
Return on Equity (ROE) -1.30

Liquidity (mrq)
Quick Ratio 4.67
Current Ratio 4.67

Balance Sheet (mrq) ($M)
Current Assets 60.48
Assets 61.88
Liabilities 68.01
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -42.10
Net Income -41.52
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -28.85
Cash from Investing 8.28
Cash from Financing 32.12

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-30 13G/A Integrated Core Strategies (us) Llc 0.60 -88.41
04-22 13G/A BlackRock, Inc. 0.00 -100.00
02-14 13G/A Rtw Investments, Lp 9.99 68.13
07-16 13D/A Alta Fundamental Advisers LLC 4.99 59.07

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUA
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 169,135 588,305 28.75
2025-05-29 85,616 516,482 16.58
2025-05-28 98,178 599,953 16.36
2025-05-27 355,007 1,765,602 20.11

(click for more detail)

Similar Companies
MDGL – Madrigal Pharmaceuticals, Inc. MGNX – MacroGenics, Inc.
MGTX – MeiraGTx Holdings plc MLYS – Mineralys Therapeutics, Inc.
MNMD – Mind Medicine (MindMed) Inc.


Financial data and stock pages provided by
Fintel.io